Citadel J Cabasag

RWE Epidemiologist. Views my own.

[Citadel J Cabasag @citadeljc]

Our paper examining epithelial #ovariancancer survival by histological subtypes for seven countries is now published!

[Global Cancer Observatory (GCO) @GLOBOCAN_GCO]

Did you see the latest assessment of #ovariancancer survival out in @IntJCanc?

@citadeljc & colleagues provide trends of epithelial ovarian cancer incidence and survival by histological subtype in 7 high-income countries 🇦🇺🇨🇦🇩🇰🇮🇪🇳🇿🇳🇴🇬🇧.
https://t.co/16iP2GDhk1

[Global Cancer Observatory (GCO) @GLOBOCAN_GCO]

NEW in @TheLancetOncol - Cancer survival for 15 cancer types in 32 countries in Africa, central & south America and Asia.

This new #SURVCAN study finds differences in survival linked to development and availability & efficiency of health services. (1/2)
https://t.co/bC6lBLR5AD

[Citadel J Cabasag @citadeljc]

🚨 Happy to share that our paper on survival for breast, cervical, and colorectal cancer in Thailand is finally published!

https://t.co/weFi7qJKrP

[Citadel J Cabasag @citadeljc]

🚨Paper Alert 🚨 Happy to share that our paper on preventability of cancer in Europe is now published in EJC.
#CancerResearch
#Europe

https://t.co/KoeF53c0TX

[Citadel J Cabasag @citadeljc]

@SPilleron Oh no! 🙁 Hope you have a fast recovery!

[Citadel J Cabasag @citadeljc]

@Geo_Gingerbeard Go Cougs!

[Citadel J Cabasag @citadeljc]

Our systematic review paper on smoking behavior during early pandemic is finally out! Feeling grateful to have had the opportunity to work with an amazing team!

[Dr Pete Sarich @PeteSarich]

Our new systematic review explores global changes in #smoking behaviours during the early #COVID19 pandemic.

Among 24 countries, we found a 13% relative decrease in overall smoking prevalence, while for those who smoked, 21% smoked less & 27% smoked more:
https://t.co/rwtinNguep

[Allini Mafra @AlliniMafra]

https://t.co/oMn3ooyl7w

[Citadel J Cabasag @citadeljc]

🚨NEW PAPER🚨 Our study in @IntJCanc highlights the current and future burden of ovarian cancer globally, calling for global action to reduce the burden and inequality in access to quality ovarian cancer care and treatment

#ovariancancer
@GLOBOCAN_GCO
https://t.co/HnznZnMjEo

[Citadel J Cabasag @citadeljc]

Our study on pancreatic cancer survival variations by stage and age at diagnosis is now published in BJC. This cancer remains fatal and our study reinforces the need for breakthroughs in early diagnosis and treatment.

https://t.co/a1GScPcrGl

[Union for International #CancerControl @uicc]

Everyone, everywhere has the right to equitable healthcare. @OphiraG @TheLancetOncol @IARCWHO #WorldCancerDay #CloseTheCareGap

[Global Cancer Observatory (GCO) @GLOBOCAN_GCO]

Just out in @BrJCancer: 5⃣ ways to improve international comparisons of #cancersurvival using data from #cancerregistries.

Recommendations from #ICBP SURVMARK-2 study, collab between @karolinskainst @kreftregisteret @UoL_Biostats @IARCWHO @KCLcancer_pharm
https://t.co/euKG7G98sb

[Mark Rutherford @MJRutherford9]

NEW PAPER: Want to fairly compare cancer survival outcomes across groups with different other-cause mortality risks? Tired of trying to explain/interpret relative survival and "hypothetical worlds where you can't die of anything but cancer"? Have a read...
https://t.co/ph7hyK1bvr

[Global Cancer Observatory (GCO) @GLOBOCAN_GCO]

Wishing you all a wonderful festive season and #HappyHolidays from the team behind the Global Cancer Observatory - the Cancer Surveillance Branch at the International Agency for Research on Cancer🎄

[Eileen Morgan @EileenMorgan_]

“This may be because younger women have a more aggressive form of breast cancer or because they are being diagnosed at a later stage,” said the presenter of the study, Dr Eileen Morgan, of the International Agency for Research on Cancer (IARC).

[Citadel J Cabasag @citadeljc]

Check out our Letter to the Editor in @Gut_BMJ on the global burden of #PancreaticCancer including projection for 2040.

Pancreatic cancer: an increasing global public health concern https://t.co/f7TfAmgeV3

#GLOBOCAN2020 #CancerSurveillance #epitwitter
@GLOBOCAN_GCO

[Citadel J Cabasag @citadeljc]

Our paper on harmonization of cancer registry stage info for esophageal, gatric and pancreatic cancer is now available. It also includes recommendations for registries to improve cancer survival comparisons by stage. #cancersurvival
#epitwitter
https://t.co/OGPYRDS4y1

[IARC @IARCWHO]

We’re launching our first #crowdfunding campaign! 100% of the money you #donate to @IARCWHO will go to financing the equipment we need to accelerate #cancer research #IARCNC https://t.co/ZdNEtdAm9J

[Global Cancer Observatory (GCO) @GLOBOCAN_GCO]

New webinar on #Alcohol and #Cancer for #EWAC2021 @EU_EWAC

🗓️25 May 9:30-11:00 CEST

Followed by @WHO_Europe seminar for early career researchers where @HarrietJR_ @IARCWHO will take a closer look at the data 🔎

🔗Register for both events here: https://t.co/UYvy4y9fhS

[Global Cancer Observatory (GCO) @GLOBOCAN_GCO]

As part of the ICBP SURVMARK-2 study @citadeljc explored #ovariancancer survival by stage in 🇦🇺🇨🇦🇩🇰🇮🇪🇳🇿🇳🇴🇬🇧, with the greatest differences seen in older women with advanced stage disease.

#WorldOvarianCancerDay #WOCD2021 https://t.co/W4pdGTcSsn